|
|
Page No.
|
|
| 2 |
||
| 2 |
||
|
|
2 | |
|
|
4 | |
|
|
5 | |
|
|
6 | |
|
|
7 | |
|
|
June 30,
|
December 31,
|
||||||
|
2023
|
2022
|
|||||||
|
(unaudited)
|
||||||||
|
ASSETS
|
||||||||
|
|
||||||||
|
CURRENT ASSETS
|
||||||||
|
|
||||||||
|
Cash and cash equivalents
|
$
|
1,028
|
$
|
992
|
||||
|
Accounts receivable (Net from credit losses of $242 and $336 as of June 30, 2023 and December 31, 2022, respectively)
|
2,194
|
1,831
|
||||||
|
Prepaid expenses and other current assets
|
504
|
627
|
||||||
|
Inventories
|
2,477
|
2,624
|
||||||
|
Restricted cash
|
51
|
50
|
||||||
|
Total current assets
|
6,254
|
6,124
|
||||||
|
|
||||||||
|
LONG-TERM ASSETS
|
||||||||
|
|
||||||||
|
Operating lease right-of-use assets
|
1,226
|
1,517
|
||||||
|
Property and equipment, net
|
842
|
863
|
||||||
|
Other Assets
|
30
|
30
|
||||||
|
Total long-term assets
|
2,098
|
2,410
|
||||||
|
Total assets
|
$
|
8,352
|
$
|
8,534
|
||||
|
|
June 30,
|
December 31,
|
||||||
|
|
2023
|
2022
|
||||||
|
(unaudited)
|
||||||||
|
LIABILITIES AND SHAREHOLDERS’ DEFICIT
|
||||||||
|
CURRENT LIABILITIES
|
||||||||
|
Account payable
|
$ |
2,140
|
$ |
1,986
|
||||
|
Accrued compensation
|
777
|
881
|
||||||
|
Other accrued liabilities
|
852
|
846
|
||||||
|
Current portion of deferred revenue
|
1,286
|
1,362
|
||||||
|
Operating lease liabilities
|
657
|
648
|
||||||
|
Line of Credit
|
5,617
|
4,650
|
||||||
|
Warranty obligations
|
176
|
182
|
||||||
|
Total current liabilities
|
11,505
|
10,555
|
||||||
|
|
||||||||
|
LONG-TERM LIABILITIES
|
||||||||
|
Convertible notes
|
1,247
|
1,221
|
||||||
|
Deferred revenues, net of current portion
|
861
|
924
|
||||||
|
Long-term operating leases Liabilities
|
632
|
935
|
||||||
|
Warranty obligations
|
356
|
323
|
||||||
|
Total long-term liabilities
|
3,096
|
3,403
|
||||||
|
|
||||||||
|
Total liabilities
|
14,601
|
13,958
|
||||||
|
|
||||||||
|
COMMITMENTS AND CONTINGENT LIABILITIES
|
||||||||
|
Redeemable preferred shares of $0.0001 par value – Authorized: 11,370,000 shares on June 30, 2023 and December 31,
2022; Issued and outstanding: 10,766,575 shares on June 30, 2023 and December 31, 2022
|
34,198
|
34,198
|
||||||
|
Shareholders’ Deficit:
|
||||||||
|
|
||||||||
|
Common shares of $0.0001per value- Authorized:
20,000,000 shares at June 30,2023 and at December 31, 2022; Issued and Outstanding: 948,424 shares at June 30, 2023 and December 31, 2022.
|
1 |
1 |
||||||
|
Additional paid-in capital
|
2,450
|
2,450
|
||||||
|
Accumulated deficit
|
(42,898
|
)
|
(42,073
|
)
|
||||
|
Total shareholders’ Deficit
|
(40,447
|
)
|
(39,622
|
)
|
||||
|
Total Liabilities, Redeemable convertible preferred shares, Common shares and Shareholders' Deficit
|
$
|
8,352
|
$
|
8,534
|
||||
|
|
Three Months Ended
June 30,
|
Six Months Ended
June 30,
|
||||||||||||||
|
|
2023
|
2022
|
2023
|
2022
|
||||||||||||
|
Revenues
|
$ |
4,886
|
$ |
4,524
|
$ |
9,554
|
$ |
9,297
|
||||||||
|
Cost of revenues
|
2,956
|
2,209
|
5,565
|
4,707
|
||||||||||||
|
|
||||||||||||||||
|
Gross profit
|
1,930
|
2,315
|
3,989
|
4,590
|
||||||||||||
|
|
||||||||||||||||
|
Operating expenses:
|
||||||||||||||||
|
Research and development
|
421
|
436
|
832
|
899
|
||||||||||||
|
Sales and marketing
|
1,303
|
1,281
|
2,628
|
2,429
|
||||||||||||
|
General and administrative
|
442
|
413
|
839
|
731
|
||||||||||||
|
|
||||||||||||||||
|
Total operating expenses
|
2,166
|
2,130
|
4,299
|
4,059
|
||||||||||||
|
|
||||||||||||||||
|
Operating (loss)/ income
|
(236
|
)
|
185
|
(310
|
)
|
531
|
||||||||||
|
Financial expenses, net
|
271
|
213
|
530
|
418
|
||||||||||||
|
Other income
|
8
|
376
|
15
|
375
|
||||||||||||
|
|
||||||||||||||||
|
Net (loss)/ Income
|
$ |
(499
|
)
|
$ |
348
|
$
|
(825
|
)
|
$ |
488
|
||||||
|
Redeemable convertible
preferred share
|
Common Share
|
Additional
paid-in
|
Accumulated
|
Total
shareholders’
|
||||||||||||||||||||||||
|
Number
|
Amount
|
Number
|
Amount
|
capital
|
deficit
|
deficit
|
||||||||||||||||||||||
|
Balance as of March 31, 2022
|
10,766,575
|
$
|
34,198
|
948,424
|
$
|
1
|
$ |
2,447
|
$
|
(41,973
|
)
|
$ |
(39,525
|
)
|
||||||||||||||
|
Share-based compensation to employees
|
-
|
-
|
-
|
-
|
2
|
-
|
2
|
|||||||||||||||||||||
|
Net income
|
-
|
-
|
-
|
-
|
-
|
348
|
348
|
|||||||||||||||||||||
|
Balance as of June 30, 2022
|
10,766,575
|
|
34,198
|
948,424
|
|
1
|
2,449
|
(41,625
|
)
|
(39,175
|
)
|
|||||||||||||||||
|
|
||||||||||||||||||||||||||||
|
Balance as of March 31, 2023
|
10,766,575
|
|
34,198
|
948,424
|
|
1
|
2,450
|
|
(42,399
|
)
|
(39,948
|
)
|
||||||||||||||||
|
Net loss
|
-
|
-
|
-
|
-
|
-
|
(499
|
)
|
(499
|
)
|
|||||||||||||||||||
|
Balance as of June 30, 2023
|
10,766,575
|
$
|
34,198
|
948,424
|
$
|
1
|
$ |
2,450
|
$
|
(42,898
|
)
|
$ |
(40,447
|
)
|
||||||||||||||
|
Redeemable convertible
preferred share
|
Common Share
|
Additional
paid-in
|
Accumulated
|
Total
shareholders’
|
||||||||||||||||||||||||
|
Number
|
Amount
|
Number
|
Amount
|
capital
|
deficit
|
deficit
|
||||||||||||||||||||||
|
Balance as of December 31, 2021
|
10,766,575
|
$
|
34,198
|
948,424
|
$
|
1
|
$ |
2,446
|
$
|
(42,113
|
)
|
$
|
(39,666
|
)
|
||||||||||||||
|
Share-based compensation to employees
|
-
|
-
|
-
|
-
|
3
|
-
|
3
|
|||||||||||||||||||||
|
Net income
|
-
|
-
|
-
|
-
|
-
|
488
|
488
|
|||||||||||||||||||||
|
Balance as of June 30, 2022
|
10,766,575
|
|
34,198
|
948,424
|
|
1
|
2,449
|
(41,625
|
)
|
(39,175
|
)
|
|||||||||||||||||
|
|
||||||||||||||||||||||||||||
|
Balance as of December 31, 2022
|
10,766,575
|
|
34,198
|
948,424
|
|
1
|
2,450
|
|
(42,073
|
)
|
|
(39,622
|
)
|
|||||||||||||||
|
Net loss
|
-
|
-
|
-
|
-
|
-
|
(825
|
)
|
(825
|
)
|
|||||||||||||||||||
|
Balance as of June 30, 2023
|
10,766,575
|
$
|
34,198
|
948,424
|
$
|
1
|
$ |
2,450
|
$ |
(42,898
|
)
|
$ |
(40,447
|
)
|
||||||||||||||
|
|
Six Months Ended
June 30, |
|||||||
|
|
2023
|
2022
|
||||||
|
Cash flows used in operating activities:
|
||||||||
|
Net (loss) Income
|
$
|
(825
|
)
|
$
|
488
|
|||
|
Adjustments to reconcile net income (loss) to
net cash used in operating activities:
|
||||||||
|
Depreciation
|
194
|
145
|
||||||
|
Amortization of debt discount and issuance costs of convertible notes
|
153 |
231 |
||||||
|
Share-based compensation expense
|
-
|
3
|
||||||
|
Changes in assets and liabilities:
|
||||||||
|
Accounts receivables, net
|
(363
|
)
|
201 |
|||||
|
Prepaid expenses and other current assets
|
123
|
(444
|
)
|
|||||
|
Inventory, net
|
2
|
(548
|
)
|
|||||
|
Other assets
|
(1 |
) |
(5
|
)
|
||||
|
Accounts payable
|
154
|
(435
|
)
|
|||||
|
Other accrued liabilities and warranties obligation
|
33 |
(168
|
)
|
|||||
|
Accrued compensation
|
(104
|
)
|
(82
|
)
|
||||
|
Change in operating leases assets and liabilities
|
(3
|
)
|
24
|
|||||
|
Deferred revenue
|
(139
|
)
|
(261
|
)
|
||||
|
Net cash used in operating activities
|
(776
|
)
|
(851
|
)
|
||||
|
|
||||||||
|
Cash flows used in investing activities:
|
||||||||
|
Purchases of property and equipment
|
(28
|
)
|
(31
|
)
|
||||
|
Net cash used in investing activities
|
(28
|
)
|
(31
|
)
|
||||
|
|
||||||||
|
Cash flows from financing activities:
|
||||||||
|
Repayments on a revolver credit line
|
(9,225
|
)
|
(9,539
|
)
|
||||
|
Proceeds from a revolver credit line, net of debt issuance costs
|
10,065
|
10,350
|
||||||
|
Net cash provided by financing activities
|
840
|
811
|
||||||
|
|
||||||||
|
Net increase (decrease) in cash and cash
equivalents
|
36
|
(71
|
)
|
|||||
|
Cash and cash equivalents at beginning of year
|
992
|
1,125
|
||||||
|
Cash and cash equivalents at end of period
|
$
|
1,028
|
$
|
1,054
|
||||
|
Supplemental disclosures of non-cash flow information
|
||||||||
|
Lease liabilities arising from new right-of-use assets
|
$ |
-
|
$ |
2,080
|
||||
|
Supplemental disclosures of other cash flow information
|
||||||||
|
Cash paid for income taxes
|
$ |
12 |
$ |
16 |
||||
|
Cash paid for interest
|
$ |
403 |
$ |
291 |
||||
| a. |
AlterG, Inc. (the “Company”) was initially incorporated in Delaware on October 21, 2004 under the name of Gravus, Inc. On June 30, 2005, the Company changed its name
and re-incorporated in Delaware under the name of AlterG, Inc. The Company’s headquarters is located in Fremont, California. The Company develops, manufactures, and markets anti-gravity treadmills for use in physical and neurological
rehabilitation and athletic training, both domestically and internationally. This transformative technology use patented, NASA-derived Differential Air Pressure technology to reduce the effects of gravity and allow people to move in new ways
with finely calibrated support and reduced pain.
|
| b. |
The financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") and are denominated in U.S.
dollars. The Company’s fiscal year ends on December 31.
|
| c. |
On August 11, 2023, the Company entered into a share purchase agreement ("The merger") with ReWalk Robotics Inc., a medical device company that designs, develops and
commercializes powered solutions which provide gait training and mobility for individuals with lower limb disabilities, whereby ReWalk Robotics Inc. acquired all of the shares of AlterG Inc. from its shareholders. The aggregate purchase price
amounted to acquired AlterG Inc. (“the Company”), for a total consideration of $19,000 in cash subject to working capital and other customary purchase price adjustments. Additional cash earnouts (in an anticipated amount of approximately
$4,000 in the aggregate) may be paid based upon a percentage of AlterG’s year-over-year future revenue growth over the next two years subject to working capital and other customary purchase price adjustments.
|
| d. |
The Company’s accumulated deficit as of June 30, 2023 was $42,898, the cash and cash equivalents balance as of June
30, 2023 was $1,028 and during the six months ended June 30, 2023, the Company's negative cash flows used in operating activities was $776.
ReWalk Robotics Ltd., the parent company, committed to financially support any deficits incurred by the
Company into the foreseeable future, if such support will be required.
|
| a. |
Revenue recognition
|
|
|
Three Months Ended
June 30, |
Six Months Ended
June 30, |
||||||||||||||
|
|
2023
|
2022
|
2023
|
2022
|
||||||||||||
|
Product
|
$
|
4,011
|
$
|
3,563
|
$
|
7,876
|
$
|
7,363
|
||||||||
|
Extended warranty
|
509
|
445
|
901
|
883
|
||||||||||||
|
Rental*
|
173
|
256
|
374
|
532
|
||||||||||||
|
Service
|
170
|
225
|
359
|
480
|
||||||||||||
|
Other
|
23
|
35
|
44
|
39
|
||||||||||||
|
Total Revenues
|
$
|
4,886
|
$
|
4,524
|
$
|
9,554
|
$
|
9,297
|
||||||||
| b. |
Concentration of Credit and Other Risks
|
| c. |
New Accounting Pronouncement
|
|
Inventory consisted of the following at:
|
June 30,
|
December 31,
|
||||||
|
2023
|
2022
|
|||||||
|
Raw materials
|
$
|
1,847
|
$
|
2,126
|
||||
|
Finished goods
|
630
|
498
|
||||||
|
Total inventory, net
|
$
|
2,477
|
$
|
2,624
|
||||
|
Authorized
shares
|
Shares issued
and outstanding
|
Redemption
value
|
Carrying value
|
|||||||||||||
|
Series A
|
800,000
|
634,461
|
$
|
2,347,486
|
$
|
2,158,206
|
||||||||||
|
Series A-1
|
475,000
|
377,248
|
1,906,184
|
1,879,116
|
||||||||||||
|
Series B
|
1,600,000
|
1,583,217
|
7,999,993
|
8,000,000
|
||||||||||||
|
Series C
|
4,700,000
|
4,463,068
|
16,513,284
|
16,256,240
|
||||||||||||
|
Series C-2
|
45,000
|
39,848
|
147,435
|
147,439
|
||||||||||||
|
Series D
|
3,750,000
|
3,668,733
|
6,147,329
|
5,756,890
|
||||||||||||
|
11,370,000
|
10,766,575
|
$
|
35,061,711
|
$
|
34,197,891
|
|||||||||||
| ● |
Holders of Series D preferred share are entitled to receive, prior and in preference to any distribution of any of the assets or surplus funds of the
corporation to the holders of Series A preferred share, Series A-1 preferred share, Series B preferred share, Series C preferred share, Series C-2 preferred share, and common share, the amount of $1.6756 per share plus all declared but
unpaid dividends. In the event the Company has insufficient assets to make such a payment, these shareholders would be paid ratably in proportion to the full amounts to which they would otherwise be respectively entitled.
|
| ● |
Upon completion of the above distributions, holders of Series C preferred share are entitled to receive, prior and in preference to any distribution of any
of the assets or surplus funds of the corporation to the holders of Series A preferred share, Series A-1 preferred share, Series B preferred share, Series C-2 preferred share, and common share, the amount of $3.70 per share plus all
declared but unpaid dividends. In the event the Company has insufficient assets to make such a payment, these shareholders would be paid ratably in proportion to the full amounts to which they would otherwise be respectively entitled.
|
| ● |
Upon completion of the above distribution, holders of Series B and Series C-2 preferred share are entitled to receive, prior and in preference to any
distribution of any of the assets or surplus funds of the corporation to the holders of Series A preferred share, Series A-1 preferred share, and common share, the amount of $5.053 per share and $3.70 per share, respectively, plus all
declared but unpaid dividends. In the event the Company has insufficient assets to make such a payment, these shareholders would be paid ratably in proportion to the full amounts to which they would otherwise be respectively entitled.
|
| ● |
Upon completion of the above distributions, holders of Series A and Series A-1 preferred share are entitled to receive, prior and in preference to any
distribution of any of the assets or surplus funds of the corporation to the holders of common share, the amount of $3.70 per share and $5.053 per share, respectively plus all declared but unpaid dividends. In the event the Company has
insufficient assets to make such a payment, these shareholders would be paid ratably in proportion to the full amounts to which they would otherwise be respectively entitled.
|
| ● |
After the above preferences have been satisfied in full, all remaining assets of the Company legally available for distribution would be distributed among
the holders of shares of Series A, Series A-1, Series B, Series C, Series C-2, and Series D preferred share and common share pro rata based on the number of common shares issued or issuable upon conversion of the preferred shares to common
share, up to $7.40 per share, $10.106 per share, $10.106 per share, $14.80 per share, and $6.7024 per share of Series A, Series A-1, Series B, Series C, Series C-2 preferred share, and Series D preferred share respectively. Thereafter, any
remaining funds would be distributed pro rata to the common shareholders based on the number of common shares held.
|
| ● |
The holders of the outstanding shares of Series A and Series A-1 preferred share do not have stated redemption rights; however, the rights and preferences of
the convertible preferred share provide for a deemed liquidation of the shares in the event of a sale of all or substantially all of the Company’s assets, the merger or consolidation of the Company, or upon the sale of more than 50% of the
voting power of the Company.
|
| ● |
The holders of the Series A, A-1, B, C, C-2, and D preferred share control a majority of the voting power of the Company’s capital share and have the right
to designate a majority of the members of the Board of Directors.
|